ASX - By Stock
|
RSH |
Re:
Ann: RSH acquires US based Access RPM, capital raise and new NED
|
|
lucasq
|
44 |
15K |
3 |
25/05/23 |
25/05/23 |
ASX - By Stock
|
44
|
15K
|
3
|
|
ASX - By Stock
|
RSH |
Re:
Ann: RSH acquires US based Access RPM, capital raise and new NED
|
|
lucasq
|
44 |
15K |
4 |
25/05/23 |
25/05/23 |
ASX - By Stock
|
44
|
15K
|
4
|
|
ASX - By Stock
|
RSH |
Re:
Ann: RSH acquires US based Access RPM, capital raise and new NED
|
|
lucasq
|
44 |
15K |
8 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
44
|
15K
|
8
|
|
ASX - By Stock
|
RSH |
Re:
Ann: RSH acquires US based Access RPM, capital raise and new NED
|
|
lucasq
|
44 |
15K |
1 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
44
|
15K
|
1
|
|
ASX - By Stock
|
RSH |
Re:
Ann: RSH acquires US based Access RPM, capital raise and new NED
|
|
lucasq
|
44 |
15K |
4 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
44
|
15K
|
4
|
|
ASX - By Stock
|
RSH |
Re:
Ann: RSH acquires US based Access RPM, capital raise and new NED
|
|
lucasq
|
44 |
15K |
3 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
44
|
15K
|
3
|
|
ASX - By Stock
|
RSH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
lucasq
|
55 |
11K |
7 |
28/04/23 |
28/04/23 |
ASX - By Stock
|
55
|
11K
|
7
|
|
ASX - By Stock
|
RSH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
lucasq
|
55 |
11K |
6 |
28/04/23 |
28/04/23 |
ASX - By Stock
|
55
|
11K
|
6
|
|
ASX - By Stock
|
RSH |
Re:
Ann: Medical Advisory Board established in US with leading KOLs
|
|
lucasq
|
8 |
1.9K |
4 |
23/02/23 |
23/02/23 |
ASX - By Stock
|
8
|
1.9K
|
4
|
|
ASX - By Stock
|
RSH |
Re:
Ann: wheezo RPM program expands into New Mexico USA
|
|
lucasq
|
9 |
3.1K |
7 |
16/12/22 |
16/12/22 |
ASX - By Stock
|
9
|
3.1K
|
7
|
|
ASX - By Stock
|
RSH |
Re:
Ann: First patients selected and enrolled into Minnesota Lung Ctr
|
|
lucasq
|
13 |
3.0K |
6 |
16/12/22 |
16/12/22 |
ASX - By Stock
|
13
|
3.0K
|
6
|
|
ASX - By Stock
|
RSH |
Re:
Ann: First primary care practice secured and first patients
|
|
lucasq
|
26 |
5.6K |
5 |
07/12/22 |
07/12/22 |
ASX - By Stock
|
26
|
5.6K
|
5
|
|
ASX - By Stock
|
RSH |
Re:
Ann: Minnesota Lung Centre select wheezo and RMP for pilot prog.
|
|
lucasq
|
18 |
5.1K |
6 |
18/11/22 |
18/11/22 |
ASX - By Stock
|
18
|
5.1K
|
6
|
|
ASX - By Stock
|
RSH |
Re:
Ann: Key milestone - First patients enrol into wheezo RPM program
|
|
lucasq
|
27 |
7.5K |
7 |
08/11/22 |
08/11/22 |
ASX - By Stock
|
27
|
7.5K
|
7
|
|
ASX - By Stock
|
RSH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
lucasq
|
7 |
2.0K |
7 |
26/10/22 |
26/10/22 |
ASX - By Stock
|
7
|
2.0K
|
7
|
|
ASX - By Stock
|
RSH |
Re:
Ann: Cost optimisation with senior executive remuneration
|
|
lucasq
|
13 |
4.4K |
4 |
05/10/22 |
05/10/22 |
ASX - By Stock
|
13
|
4.4K
|
4
|
|
ASX - By Stock
|
RSH |
Re:
Ann: Cost optimisation with senior executive remuneration
|
|
lucasq
|
13 |
4.4K |
10 |
05/10/22 |
05/10/22 |
ASX - By Stock
|
13
|
4.4K
|
10
|
|
ASX - By Stock
|
RSH |
Re:
Ann: Wheezo successfully integrated in Michigan Children Hospital
|
|
lucasq
|
39 |
9.2K |
7 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
39
|
9.2K
|
7
|
|
ASX - By Stock
|
RSH |
Re:
Ann: Wheezo successfully integrated in Michigan Children Hospital
|
|
lucasq
|
39 |
9.2K |
7 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
39
|
9.2K
|
7
|
|
ASX - By Stock
|
RSH |
Re:
Ann: New GBP2m NIHR-Funded UK Paediatric Asthma Clinical Trial
|
|
lucasq
|
54 |
11K |
0 |
15/07/22 |
15/07/22 |
ASX - By Stock
|
54
|
11K
|
0
|
|
ASX - By Stock
|
RSH |
Re:
Ann: New GBP2m NIHR-Funded UK Paediatric Asthma Clinical Trial
|
|
lucasq
|
54 |
11K |
1 |
13/07/22 |
13/07/22 |
ASX - By Stock
|
54
|
11K
|
1
|
|
ASX - By Stock
|
RSH |
Re:
Ann: New GBP2m NIHR-Funded UK Paediatric Asthma Clinical Trial
|
|
lucasq
|
54 |
11K |
2 |
13/07/22 |
13/07/22 |
ASX - By Stock
|
54
|
11K
|
2
|
|
ASX - By Stock
|
RSH |
Re:
Ann: New GBP2m NIHR-Funded UK Paediatric Asthma Clinical Trial
|
|
lucasq
|
54 |
11K |
2 |
13/07/22 |
13/07/22 |
ASX - By Stock
|
54
|
11K
|
2
|
|
ASX - By Stock
|
RSH |
Re:
Ann: New GBP2m NIHR-Funded UK Paediatric Asthma Clinical Trial
|
|
lucasq
|
54 |
11K |
3 |
12/07/22 |
12/07/22 |
ASX - By Stock
|
54
|
11K
|
3
|
|
ASX - By Stock
|
RSH |
Re:
Ann: New GBP2m NIHR-Funded UK Paediatric Asthma Clinical Trial
|
|
lucasq
|
54 |
11K |
7 |
12/07/22 |
12/07/22 |
ASX - By Stock
|
54
|
11K
|
7
|
|
ASX - By Stock
|
RSH |
Re:
Ann: New GBP2m NIHR-Funded UK Paediatric Asthma Clinical Trial
|
|
lucasq
|
54 |
11K |
7 |
12/07/22 |
12/07/22 |
ASX - By Stock
|
54
|
11K
|
7
|
|
ASX - By Stock
|
RSH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
lucasq
|
36 |
10K |
6 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
36
|
10K
|
6
|
|
ASX - By Stock
|
RSH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
lucasq
|
36 |
10K |
5 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
36
|
10K
|
5
|
|
ASX - By Stock
|
RSH |
Re:
Ann: Copy of investor presentation
|
|
lucasq
|
7 |
2.7K |
5 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
7
|
2.7K
|
5
|
|
ASX - By Stock
|
RSH |
Re:
Ann: EAS Advisors LLC appointed to assist with US growth
|
|
lucasq
|
36 |
13K |
7 |
19/04/22 |
19/04/22 |
ASX - By Stock
|
36
|
13K
|
7
|
|
ASX - By Stock
|
RSH |
Re:
Ann: EAS Advisors LLC appointed to assist with US growth
|
|
lucasq
|
36 |
13K |
6 |
29/03/22 |
29/03/22 |
ASX - By Stock
|
36
|
13K
|
6
|
|
ASX - By Stock
|
RSH |
Re:
Ann: Half Yearly Report and Accounts
|
|
lucasq
|
36 |
6.6K |
2 |
22/02/22 |
22/02/22 |
ASX - By Stock
|
36
|
6.6K
|
2
|
|
ASX - By Stock
|
RSH |
Re:
Ann: Half Yearly Report and Accounts
|
|
lucasq
|
36 |
6.6K |
4 |
22/02/22 |
22/02/22 |
ASX - By Stock
|
36
|
6.6K
|
4
|
|
ASX - By Stock
|
RSH |
Re:
Ann: Half Yearly Report and Accounts
|
|
lucasq
|
36 |
6.6K |
4 |
22/02/22 |
22/02/22 |
ASX - By Stock
|
36
|
6.6K
|
4
|
|
ASX - By Stock
|
RSH |
Re:
Ann: Half Yearly Report and Accounts
|
|
lucasq
|
36 |
6.6K |
3 |
22/02/22 |
22/02/22 |
ASX - By Stock
|
36
|
6.6K
|
3
|
|
ASX - By Stock
|
RSH |
Re:
Ann: Respiri secures a second order from mTeleHealth
|
|
lucasq
|
46 |
10K |
0 |
19/02/22 |
19/02/22 |
ASX - By Stock
|
46
|
10K
|
0
|
|
ASX - By Stock
|
RSH |
Re:
Ann: Respiri secures a second order from mTeleHealth
|
|
lucasq
|
46 |
10K |
4 |
14/02/22 |
14/02/22 |
ASX - By Stock
|
46
|
10K
|
4
|
|
ASX - By Stock
|
PCK |
Re:
PainChek General Discussion
|
|
lucasq
|
20K |
16M |
12 |
08/02/22 |
08/02/22 |
ASX - By Stock
|
20K
|
16M
|
12
|
|
ASX - By Stock
|
RSH |
Re:
Ann: Second RPM Agreement with Access TeleHealth
|
|
lucasq
|
42 |
8.2K |
1 |
07/02/22 |
07/02/22 |
ASX - By Stock
|
42
|
8.2K
|
1
|
|
ASX - By Stock
|
RSH |
Re:
Ann: Second RPM Agreement with Access TeleHealth
|
|
lucasq
|
42 |
8.2K |
5 |
07/02/22 |
07/02/22 |
ASX - By Stock
|
42
|
8.2K
|
5
|
|
ASX - By Stock
|
RSH |
Re:
Ann: Second RPM Agreement with Access TeleHealth
|
|
lucasq
|
42 |
8.2K |
5 |
07/02/22 |
07/02/22 |
ASX - By Stock
|
42
|
8.2K
|
5
|
|
ASX - By Stock
|
RSH |
Re:
Ann: Respiri secures a second order from mTeleHealth
|
|
lucasq
|
46 |
10K |
6 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
46
|
10K
|
6
|
|
ASX - By Stock
|
RSH |
Re:
Ann: Respiri enters Distribution/Marketing Agreement in USA
|
|
lucasq
|
61 |
14K |
4 |
24/12/21 |
24/12/21 |
ASX - By Stock
|
61
|
14K
|
4
|
|
ASX - By Stock
|
RSH |
Re:
Ann: Respiri enters Distribution/Marketing Agreement in USA
|
|
lucasq
|
61 |
14K |
5 |
24/12/21 |
24/12/21 |
ASX - By Stock
|
61
|
14K
|
5
|
|
ASX - By Stock
|
RSH |
Re:
Ann: Respiri enters Distribution/Marketing Agreement in USA
|
|
lucasq
|
61 |
14K |
3 |
24/12/21 |
24/12/21 |
ASX - By Stock
|
61
|
14K
|
3
|
|
ASX - By Stock
|
RSH |
Re:
Ann: Respiri enters Distribution/Marketing Agreement in USA
|
|
lucasq
|
61 |
14K |
6 |
24/12/21 |
24/12/21 |
ASX - By Stock
|
61
|
14K
|
6
|
|
ASX - By Stock
|
RSH |
Re:
Ann: Respiri enters Distribution/Marketing Agreement in USA
|
|
lucasq
|
61 |
14K |
4 |
24/12/21 |
24/12/21 |
ASX - By Stock
|
61
|
14K
|
4
|
|
ASX - By Stock
|
RSH |
Re:
Ann: Respiri enters Distribution/Marketing Agreement in USA
|
|
lucasq
|
61 |
14K |
5 |
24/12/21 |
24/12/21 |
ASX - By Stock
|
61
|
14K
|
5
|
|
ASX - By Stock
|
RSH |
Re:
Ann: Respiri enters Distribution/Marketing Agreement in USA
|
|
lucasq
|
61 |
14K |
4 |
24/12/21 |
24/12/21 |
ASX - By Stock
|
61
|
14K
|
4
|
|
ASX - By Stock
|
RSH |
Re:
Ann: Respiri enters Distribution/Marketing Agreement in USA
|
|
lucasq
|
61 |
14K |
4 |
24/12/21 |
24/12/21 |
ASX - By Stock
|
61
|
14K
|
4
|
|